Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations.

Journal of translational medicine - 22 Jan 2016

Cocca Massimiliano, Bedognetti Davide, La Bianca Martina, Gasparini Paolo, Girotto Giorgia

Abstract excerpt

BACKGROUND: Breast cancer is the most common cancer in women characterized by a high variable clinical outcome among individuals treated with equivalent regimens and novel targeted therapies. In this study, we performed a population based approach intersecting high-throughput genotype data from Friuli Venezia Giulia (FVG) isolated populations with publically available pharmacogenomics information to estimate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Geography

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Share to Precision Medicine

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 26801900
DOI: 10.1186/s12967-016-0778-z
PMCID: PMC4722680

Genes

DPYD
ERBB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations.PMID 26801900Read ↗

Pharmacogenomics in Tailoring First-Line Therapy for Breast Cancer: PharmGKB Database InsightsSemantic proximity Read ↗

Pharmacogenetics and pharmacogenomics as tools in cancer therapySemantic proximity Read ↗

Diversity of oncopharmacogenetic profile within Spanish population.Semantic proximity Read ↗

The effect of genetic variability on drug response in conventional breast cancer treatment.Semantic proximity Read ↗

Pharmacogenetics as Personalized Medicine: Association Investigation of SOD2 rs4880, CYP2C19 rs4244285, and FCGR2A rs1801274 Polymorphisms in a Breast Cancer Population in Iraqi Women.Semantic proximity Read ↗

Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patientsSemantic proximity Read ↗

Genetic Influences in Breast Cancer Drug ResistanceSemantic proximity Read ↗

The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors.Semantic proximity Read ↗

Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience.Semantic proximity Read ↗

No Evidence of Genotype‒Treatment Interactions between Endocrine Therapies and Adverse Drug Effects in Women with Breast Cancer: Findings from the UK BiobankSemantic proximity Read ↗

On the use of pharmacogenetics in cancer treatment and clinical trials.Semantic proximity Read ↗

Genomics and pharmacogenomics of breast cancer: current knowledge and trends.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.